Roderick L. Beijersbergen

The Netherlands Cancer Institute — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

57h-index23.4kcitations358works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

DNA Repair Mechanisms(38), Cancer-related Molecular Pathways(36), CRISPR and Genetic Engineering(35), Cancer Mechanisms and Therapy(33), Cancer, Hypoxia, and Metabolism(29)

Publications358 total

Supplementary Figures and Table from Inhibitor of Apoptosis Proteins Antagonist Induces T-cell Proliferation after Cross-Presentation by Dendritic Cells
2025Open Access
Cholesterol biosynthesis as a drug-induced vulnerability in diffuse large B cell lymphoma insensitive to EZH2 inhibition
Neoplasia·2025Open Access
Inducible CRISPR–Cas9 screening platform to interrogate non-proliferative cellular states
Nature Protocols·2025· 1 cited
Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models
NAR Cancer·2025· 1 citedOpen Access
CRISPR screens identify the ATPase VCP as a druggable therapeutic vulnerability in cholangiocarcinoma
Proceedings of the National Academy of Sciences·2025Open Access
Integrating computational protein structure predictions and genetic dependencies yields an atlas of human multi-protein complexes (AHMPC)
2025Open Access
Beyond Static Screens: A High-Throughput Pooled Imaging CRISPR Platform for Dynamic Phenotype Discovery
2025Open Access
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer
Cell Reports Medicine·2025· 4 citedOpen Access
4919 Moving from single cell genomics towards spatial transcriptomics
Radiotherapy and Oncology·2025
A functionally validated TCR-pMHC database for TCR specificity model development
2025· 14 citedOpen Access
Condensate screening identifies YM155 as β-catenin condensate inhibitor in colorectal cancer
2025· 3 cited
Onderzoeksmethodologie in de oncologie
2025
Molecular dependencies and genomic consequences of a global DNA damage tolerance defect
Genome biology·2024Open Access
An antibiotic that mediates immune destruction of senescent cancer cells
Proceedings of the National Academy of Sciences·2024· 8 citedOpen Access
P-stalk ribosomes act as master regulators of cytokine-mediated processes
Cell·2024· 24 citedOpen Access
An antibiotic that mediates immune destruction of senescent cancer cells
2024
ADARp150 counteracts whole genome duplication
Nucleic Acids Research·2024· 2 citedOpen Access
Figure S5 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024Open Access
Table S7 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024Open Access
Figure S6 from Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy
2024Open Access
page 1 of 18Next →

Frequent Co-authors

René Bernards(35), Cor Lieftink(14), Liqin Wang(7), Cun Wang(7), Sidong Huang(6), Katrien Berns(6), E. Marielle Hijmans(6), Jasper Mullenders(6), Bastiaan Evers(6), Haojie Jin(6), Anirudh Prahallad(5), Chong Sun(5), Federica Di Nicolantonio(5), Alberto Bardelli(5), Mandy Madiredjo(5), Ron Kerkhoven(5), Lodewyk F.A. Wessels(5), Fleur Jochems(5), Wenxin Qin(5), Robert A. Weinberg(4)